Sony Corporation

Eisai R&d Management Co., Ltd.

Genox Research, Inc.

Eisai Company, Limited

Japan as Represented by General Director of Agency of National Center for Child Health & Development

Kaoru Ogawa

Keigo Tanaka

Takeshi Nagasu

Itaru Tsukada

Kazutaka Nakamoto

Kappei Tsukahara

Katsura Hata

Koji Sagane

Toshihiro Horii

Yuji Sugita

Tomoko Fujishima

Ryoichi Hashida

Yukiho Imai

Keiko Matsui

Nei Yoshida

Gozoh Tsujimoto

Eiki Takahashi

Tadahiro Oshida

Masaya Obayashi

Shigemichi Gunji

Izumi Obayashi

The present invention prevents density irregularity from appearing in a print result and to thereby improve image quality by controlling a motor so that the rotational speed of a drive shaft that feeds printing media is constant. The present invention provides a printing media feeding apparatus including a feeding section that includes a motor, a drive transmission mechanism which transmits a driving force of the motor, and a drive shaft to which the driving force is transmitted by the drive transmission mechanism. The drive shaft is rotated to feed the printing medium. A detection section is provided having at least a portion secured to the drive shaft and the detection section determines the rotational speed of the drive shaft and a controller controls the motor based on an input from the detection section so that the rotational speed the of the drive shaft is constant.

Printing media feeding apparatus, printing apparatus provided with the feeding apparatus, printing media feeding speed control method and computer program

The present inventors succeeded in isolating GWT1 (PfGWT1), which is one of the enzymes involved in GPI biosynthesis in the malaria parasite. In addition, the inventors revealed that degenerate mutant DNAs, with a lower AT content than the DNA encoding the PfGWT1 protein, can complement the phenotype of GWT1-deficient yeast. Based on the findings, the present invention provides the GWT1 protein of malaria parasites and the use of the protein in methods of screening for antimalarial drugs. The present invention also provides degenerate mutant DNAs encoding proteins involved in GPI biosynthesis, and which have a lower AT content than the original DNAs. The present invention also provides methods of screening for antimalarial drugs which use the degenerate mutant DNAs.

Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites

Disclosed herein is a color adjustment apparatus, including: a color information storage section configured to store color information regarding an arbitrary region designated through a pointer in an editing image region; and a color coordinate explicitly displaying section configured to explicitly display a mark, which specifies color coordinates corresponding to the color information, at a pertaining position on a hue ring or a hue bar chart prepared for color adjustment.

Color adjustment apparatus, display apparatus, printing apparatus, image processing apparatus, color adjustment method, graphical user interface displaying method and program

A color adjusting apparatus includes a first storage unit for storing information indicating a hue (color phase) range arbitrarily designated in a hue space, a second storage unit for storing an adjustment value for adjusting a degree of color shift in the hue range, and a color conversion unit for performing expansion processing or compression processing on a color component of input image data, the color component being associated with the hue range, in accordance with the degree of color shift determined by the adjustment value.

Color adjusting apparatus, display apparatus, printing apparatus, image processing apparatus, color adjustment method, GUI display method, and program

The differential display method was used to search for a gene whose expression level in eosinophils collected from patients with atopic dermatitis differs in the exacerbation stage and in the remission stage. As a result, gene '2090-05' showing a significant increase in expression in eosinophils of patients in the remission stage was isolated. This gene is usable in testing for an allergic disease and screening for a candidate compound for a therapeutic agent therefor an allergic disease.

Method of testing for allergic diseases

T cells from multiple subjects who showed different cedar pollen specific IgE titers were prepared before and after cedar pollen dispersal, and differential display analysis was performed to screen for pollen antigen responsive genes. As a result, a novel gene was successfully isolated whose expression is significantly higher in subjects with high cedar pollen specific IgE titer. The inventors have found that it is possible to use this gene to test for an allergic disease and to screen for candidate compounds for therapeutic drugs for an allergic disease.

Pollen allergy-related gene 513

Growing community of inventors

Kanagawa, Japan

Kaoru Ogawa